Catalyst Wire Dossier Catalyst Wire Dossier

PEHRG214

· Virionyx Corporation Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PEHRG214, covering 2010-08-26 to 2010-08-26. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of PEHRG214 in HIV-Infected Patients [Phase 2]

See pricing